Mar 20, 2017 11:30 am UTC| Business
NEW YORK, March 20, 2017 -- TG Therapeutics, Inc. (NASDAQ:TGTX), today announced that preclinical data for the Company’s anti-PD-L1 monoclonal antibody, has been selected for presentation at the upcoming American...
Mar 20, 2017 11:30 am UTC| Business
YARDLEY, Pa., March 20, 2017 -- Alliqua BioMedical, Inc. (Nasdaq:ALQA) ("Alliqua" or "the Company"), a regenerative technologies company committed to restoring tissue and rebuilding lives, today announced the...
Mar 20, 2017 11:30 am UTC| Business
BOSTON, March 20, 2017 -- Keryx Biopharmaceuticals, Inc. (Nasdaq:KERX), a biopharmaceutical company focused on bringing innovative medicines to people with renal disease, today announced that the nation’s largest...
SemGroup Corporation Announces New Board Member
Mar 20, 2017 11:29 am UTC| Business
TULSA, Okla., March 20, 2017 -- SemGroup® Corporation (NYSE:SEMG) announced today that W.J. “Bill” McAdam has been elected as the newest member of the SemGroup Board of Directors. Mr. McAdam is filling the vacancy on...
Mar 20, 2017 11:29 am UTC| Business
TORONTO, March 20, 2017 -- Profound Medical Corp. (TSX-V:PRN) (OTCQX:PRFMF) (“Profound” or the “Company”) an emerging medical device company focused on prostate care, today announced that it has successfully completed...
Mar 20, 2017 11:07 am UTC| Business
SAN DIEGO, March 20, 2017 -- Amydis Diagnostics, Inc., a preclinical stage, privately-held pharmaceutical company developing proprietary chemistry and innovative approaches to detection of amyloid-related...
Mar 20, 2017 11:05 am UTC| Business
SALT LAKE CITY, March 20, 2017 -- Myriad Genetics, Inc. (NASDAQ:MYGN), a leader in molecular diagnostics and personalized medicine, today announced that the company will present five scientific posters at the 2017...